Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.
Sulfocerebrosides upregulate liposome uptake in human astrocytes without inducing a proinflammatory response.
Characterising aggressive multiple sclerosis.
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
The Volume Activated Potassium Channel KCNK5 is Up-Regulated in Activated Human T Cells, but Volume Regulation is Impaired.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways.
Distribution of axon diameters in cortical white matter: an electron-microscopic study on three human brains and a macaque.
Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems.
When does multiple sclerosis start? Three case reports and a review of the literature.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
[Current aspects of therapy conversion for multiple sclerosis].
How to run a multiple sclerosis relapse clinic.
The ethics of placebo controlled clinical trials in NMO - A balance of risks.
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson's and other brain diseases.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
In-home measurement of the effect of strategically weighted vests on ambulation.
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?
Promoting return of function in multiple sclerosis: An integrated approach.

Pages